-
181
Tumor microenvironment and immunotherapy for triple-negative breast cancer
Published 2024-12-01Subjects: Get full text
Article -
182
Characterization of G2/M checkpoint classifier for personalized treatment in uterine corpus endometrial carcinoma
Published 2025-02-01Subjects: Get full text
Article -
183
-
184
Baseline (derived) neutrophil-lymphocyte ratio associated with survival in gastroesophageal junction or gastric cancer treated with ICIs
Published 2025-01-01Subjects: “…immune checkpoint inhibitors…”
Get full text
Article -
185
Chemotherapy in synergy with innate immune agonists enhances T cell priming for checkpoint inhibitor treatment in pancreatic cancer
Published 2025-01-01Subjects: Get full text
Article -
186
Dissociated response and treatment outcome with immune checkpoint blockade in advanced cancer
Published 2024-12-01Subjects: Get full text
Article -
187
Case report: A case of type 1 diabetes with diabetic ketoacidosis induced by envafolimab treatment in hepatocellular carcinoma
Published 2025-01-01Subjects: Get full text
Article -
188
-
189
CD73/adenosine dynamics in treatment-induced pneumonitis: balancing efficacy with risks of adverse events in combined radio-immunotherapies
Published 2025-01-01Subjects: Get full text
Article -
190
Interdependence of coagulation with immunotherapy and BRAF/MEK inhibitor therapy: results from a prospective study
Published 2024-11-01Subjects: “…Immune checkpoint inhibitors…”
Get full text
Article -
191
Fusobacterium nucleatum upregulates the immune inhibitory receptor PD-L1 in colorectal cancer cells via the activation of ALPK1
Published 2025-12-01Subjects: Get full text
Article -
192
The characteristics of the tumor immune microenvironment in colorectal cancer with different MSI status and current therapeutic strategies
Published 2025-01-01Subjects: Get full text
Article -
193
The clinical significance of T cell infiltration and immune checkpoint expression in central nervous system germ cell tumors
Published 2025-01-01Subjects: Get full text
Article -
194
Efficacy of first-line chemotherapy combined with immunotherapy or anti-angiogenic therapy in advanced KRAS-mutant non-small cell lung cancer
Published 2025-03-01Subjects: Get full text
Article -
195
-
196
Prognostic value of systemic immune-inflammation index in patients with small-cell lung cancer treated with immune checkpoint inhibitors
Published 2025-01-01Subjects: Get full text
Article -
197
Exploring the role of metabolic pathways in TNBC immunotherapy: insights from single-cell and spatial transcriptomics
Published 2025-01-01Subjects: Get full text
Article -
198
Assessing hemorrhagic risks in combination therapy: implications of angiogenesis inhibitors and immune checkpoint inhibitors
Published 2025-02-01Subjects: “…immune checkpoint inhibitors…”
Get full text
Article -
199
DNA methylation and immune evasion in triple-negative breast cancer: challenges and therapeutic opportunities
Published 2025-02-01Subjects: Get full text
Article -
200
Macrophages facilitate tumor cell PD‐L1 expression via an IL‐1β‐centered loop to attenuate immune checkpoint blockade
Published 2023-04-01Subjects: “…immune checkpoint blockade…”
Get full text
Article